Oil palm leaf fibre and its suitability for paper-based products

Due to the shortage of wood as origin materials for paper-based production, agro-residue materials have been explored in the quest of finding the best alternative fibre. Oil palm leaf (OPL) is one of agro-residue that has potential due to its comparable characteristics with wood fibre. Studies on chemical compositions, fibre morphology, and mechanical property of OPL have been carried out aiming to evaluate its potential as a substitute raw material for pulp and paper-based production. The chemical compositions were analysed according to the TAPPI standard, Kurscher-Hoffner and chlorite methods accordingly. The mechanical property (tensile, tearing and bursting strengths) were determined as described in TAPPI test methods. Fibre dimensions were determined using Franklin method and analysed under the optical microscope. The content of cellulose in the OPL is determined to be 43.8%. Although, this result is lower than wood fibre (53%), OPL has higher hemicellulose content (36.4%) than the wood fibre (27.5%). In addition, the lignin content (19.7%) of OPL is in the low range of those in wood resources (18 - 25%). These parameters are important components to produce good quality pulp and will provide high mechanical strength of the paper-based products. The measured fibre length of oil palm leaf (1.13 mm) is shorter than the wood fibre (1.90 mm). Meanwhile, the mechanical property of OPL showed lower indexes than wood resources, however, tear (1.80 mN.m2/g) and burst (0.95 kPa.m2/g) indexes of OPL are higher than other published and successful wood resources (Eucalyptus). Based on the analyses, the oil palm leaf is indeed a suitable alternative of raw material for pulp and paper-based industries

Morphological characteristics of black aspergilli isolated from clinical wastes

The present study aimed to recognize the microscopic characteristics of black aspergilli species which exhibit similar characteristics on culture media. Forty eight black aspergilli isolates were obtained from clinical wastes and purified using single spore technique on six different culture media. The ultrastructure of fungal conidiophore and spores was detected by using Scanning Electron Microscope (SEM). The fungal isolates were identified within five species included A. niger, A. tubingensis, Aspergillus section Nigri, A. violaceofuscus, A. neoniger. Besides, two isolates identified as Aspergillus sp. strain no. 39, Aspergillus sp. strain no. 53 appear as new strains based on the structure of conidiophore and spores. The fungi species have similar culture characteristics. However, SEM observation demonstrated that they have quite different conidiophore and spores morphology. The study revealed that the microstructure of the fungal spores and conidiophores plays an important role in the identification of fungi species based on the phenotypic method

CFD Simulation Analysis of Non-Premixed Combustion using a Novel AxialRadial Combined Swirler for Emission Reduction Enhancement

Combustion industries for many decades dealing with the issues in reducing the emissions without affecting the performance of combustion. The present study aims to investigate the performance of swirler mechanism which combining between both axial and radial types to reduce emissions and increase the mixing process via the nonpremixed method. Each of axial and radial swirler consisted with 8 blades vane. Swirl angle for radial swirler is 35° and inclination angle for axial swirler is 15°. The swirler is designed using Solidworks software package and CFD analysis was then performed using ANSYS Fluent software package. The fuel used is liquefied petroleum gas (LPG) gas which contained 30% propane and 70% butane. The turbulence model standard kepsilon was used in this study. The result found that the combined swirler was capable to reduce CO emission as the complete reaction into CO2 component was higher. This is due to the broader region of temperature and higher velocity magnitude produced by the combined swirler. However, the maximum temperature result for axial swirler was higher than the combined swirler. As a recommendation, the inclination blade angle in the axial swirler of the combined swirler should be increased to increase the temperature value

Reduction of bacteria in storage system of sewage effluents

The present work is aimed to investigate the linear regression model of total coliform (TC), faecal coli-form (FC) and enterococci (ENT) responses in the storage system of sewage effluents at different temperatures (room temperature 25 ± 2 °C, 55 and 65 °C). Five litres (v/v) of sewage effluent samples was stored at room temperature (25 ± 2 °C) for 1, 2, 3 and 4 weeks. In order to investigate the response of bacteria to the storage system at thermal conditions, the sewage samples were stored at the tempera-tures of 55 and 65 °C in a water bath shaker for 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110 and 120 min, respectively. The results indicated that the storage system at room tem-perature significantly (p < 0.01) effected the reduction of TC (33%), FC (36.6%) and ENT (47.8%). Moreover, sew-age effluent met WHO guidelines after two weeks of stor-age period at room temperature. The storage system at 55 and 65 °C had more significant influence (p < 0.01) on TC, FC and ENT. The reductions for TC, FC and ENT were 49.6 versus 64, 47.7 versus 83.2% and 47.4 versus 57.3%, respectively. ENT (Gram-positive bacteria) exhibited more resistance to the storage system at 65 °C than TC and FC (both are Gram-negative bacteria). This might be due to the differences in the cell wall structure. It can be concluded that the storage system of sewage effluents has a significant potential for the reduction of indicator bacteria

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

Removal of pathogenic bacteria from sewage-treated effluent and biosolids for agricultural purposes

Abstract The reuse of treated sewage for irrigation is considered as an important alternative water source in the new water management strategy of the countries that face a severe deficiency of water resources such as the Middle East countries. The organic material and fertilizing elements contained in biosolids are essential for maintaining soil fertility. However, both treated sewage and biosolids contain a large diversity of pathogens that would be transmitted to the environment and infect human directly or indirectly. Therefore, those pathogens should be reduced from the treated sewage and biosolids before the reuse in the agriculture. This paper reviews the considerations for reuse of treated sewage and biosolids in agriculture and further treatments used for reduction of pathogenic bacteria. The treatment methods used for the reduction of pathogens in these wastes have reviewed. It appeared that the main concern associated with the reduction of pathogenic bacteria lies in their ability to regrow in the treated sewage and biosolids. Therefore, the effective treatment method is that it has the potential to destruct pathogens cells and remove the nutrients to prevent the regrowth or recontamination from the surrounded environment. The removal of nutrients might be applicable in the sewage but not in the biosolids due to high nutrient contents. However, the reduction of health risk in the biosolids might be carried out by regulating the biosolid utilization and selecting the plant species grown in the fertilized soil with biosolids